Introduction: Continuous positive airway pressure (CPAP) is the most effective treatment for obstructive sleep apnea (OSA). Despite this, CPAP adherence reported in the literature is only two to four hours per night. Difficulty with exhalation is often cited as a reason for difficulty tolerating CPAP. It is possible that patients with high total nasal resistance (TNR) or symptoms of chronic rhinosinusitis (CRS) experience increased pressure on exhalation and this contributes to decreased adherence. The World Trade Center (WTC) First Responder cohort has a high prevalence of subjects with nasal complaints providing a unique population to understand the relationship of OSA to this condition. Methods: Subjects were enrolled from the WTC Health Program who reported no snoring in the year prior to 9/11. Subjects answered a nasal symptom questionnaire for rhinosinusitis over the previous eight weeks: facial pain/pressure, post nasal drip, sore throat, sneezing, congestion/runny nose, blocked nose or loss of smell. CRS was defined as present when there were three or more positive responses. Subjects underwent measurement of total nasal resistance via rhinomanometry and had OSA assessed with home sleep testing (ARESTM). Subjects with OSA (AHI4>5/hr or AHI4A>15/hr) were randomized to a double-blind crossover 4 week trial with CPAP or CPAP with C-Flex. CPAP adherence was monitored nightly and uploaded via modem. Adherence (hours/night and %nights >4 hours) was averaged for 2 weeks after at least 2 weeks of habituation. Data are presented here only for the first treatment period (data pooled for CPAP and C-Flex). Results: 476 subjects underwent home sleep testing, of which 359 were diagnosed with OSA. 248 subjects have undergone randomization; data from the first 182 subjects (24F/158M) are presented here. Overall CPAP compliance was poor (table 1). Gender, OSA severity or Epworth Sleepiness Score (ESS) did not affect CPAP adherence although age did (table). 48% had presence of CRS and 44% had high nasal resistance. Symptoms of CRS and nasal resistance variables did not show a statistically significant effect on CPAP adherence. However, in the small number of women (24), CRS symptoms were associated with lower adherence (p<0.05). Conclusions: Overall prevalence of OSA, CRS, and elevated nasal resistance are high in the WTC Responder population. Thus far we show no effect of awake elevated nasal resistance or CRS on CPAP adherence (CPAP and Cflex data are currently still blinded). However, we have not evaluated sleep nasal resistance as a contributing factor in CPAP adherence.
Keywords
Rescue workers; Emergency responders; Nasal cavity; Nasal disorders; First responders; World Trade Center; WTC; Sleep; Sleep disorders; Breathing apparatus; Questionnaires; Age factors; Humans; Men; Women
CODEN
AJCMED
Publication Date
20160501
Document Type
Abstract
Email Address
priya.agarwala@nyumc.org
Funding Type
Cooperative Agreement
Fiscal Year
2016
Identifying No.
Cooperative-Agreement-Number-U01-OH-010415
ISSN
1073-449X
Source Name
American Journal of Respiratory and Critical Care Medicine
State
NY; NJ
Performing Organization
RBHS-Robert Wood Johnson Medical School, Piscataway, New Jersey
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.